Avantor logo

AvantorNYSE: AVTR

Profile

Sector:

Healthcare

Country:

United States

IPO:

17 May 2019

Next earnings report:

14 February 2025

Last dividends:

N/A

Next dividends:

N/A
$15.03 B
-41%vs. 3y high
95%vs. sector
-28%vs. 3y high
77%vs. sector
-67%vs. 3y high
67%vs. sector
-37%vs. 3y high
39%vs. sector

Price

after hours | Fri, 01 Nov 2024 23:54:56 GMT
$22.08-$0.26(-1.16%)

Dividend

No data over the past 3 years
$1.71 B$1.72 B
$1.71 B$57.80 M

Analysts recommendations

Institutional Ownership

AVTR Latest News

Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down
zacks.com28 October 2024 Sentiment: NEUTRAL

Despite AVTR's continued stability in the Education and Advanced Technology end markets, it reports an overall soft third-quarter performance.

Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript
seekingalpha.com25 October 2024 Sentiment: NEUTRAL

Avantor Inc. (NYSE:AVTR ) Q3 2024 Earnings Conference Call October 25, 2024 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President and Chief Executive Officer Brent Jones - Executive Vice President and Chief Financial Officer Conference Call Participants Daniel Brennan - TD Cowen Douglas Schenkel - Wolfe Research Tycho Peterson - Jefferies Michael Ryskin - Bank of America Vijay Kumar - Evercore ISI Daniel Leonard - UBS Conor McNamara - RBC Capital Markets Daniel Arias - Stifel Rachel Vatnsdal - JP Morgan Luke Sergott - Barclays Tejas Savant - Morgan Stanley Operator Good morning. My name is Emily, and I will be your conference operator today.

Avantor (AVTR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com25 October 2024 Sentiment: POSITIVE

The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Avantor, Inc. (AVTR) Beats Q3 Earnings Estimates
zacks.com25 October 2024 Sentiment: POSITIVE

Avantor, Inc. (AVTR) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago.

Avantor® Reports Third Quarter 2024 Results
prnewswire.com25 October 2024 Sentiment: NEUTRAL

Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7% Net income of $57.8 million; Adjusted EBITDA of $302.5 million Diluted GAAP EPS of $0.08; adjusted EPS of $0.26 Operating cash flow of $244.8 million; free cash flow of $204.0 million RADNOR, Pa. , Oct. 25, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its third fiscal quarter ended September 30, 2024.

Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges
prnewswire.com23 October 2024 Sentiment: POSITIVE

Avantor and NIBRT have formed a new partnership to supply advanced Masterflex® equipment, essential products, and expert training to foster innovations in biopharma manufacturing RADNOR, Pa. , Oct. 23, 2024  /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced an expanded partnership with the National Institute for Bioprocessing Research and Training (NIBRT).

AVTR Stock Flat Following the Close of Divestiture Deal With Audax
zacks.com21 October 2024 Sentiment: NEUTRAL

Avantor closes its deal with Audax to divest its clinical services business.

Avantor® Closes Previously Announced Divestiture of its Clinical Services Business
prnewswire.com18 October 2024 Sentiment: POSITIVE

RADNOR, Pa. , Oct. 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it has closed the divestiture of its clinical services business to Audax Private Equity in a transaction valued at approximately $650 million.

MD vs. AVTR: Which Stock Should Value Investors Buy Now?
zacks.com02 October 2024 Sentiment: POSITIVE

Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?

Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management
prnewswire.com30 September 2024 Sentiment: POSITIVE

Recognition highlights commitment to Avantor Business System (ABS) principles to enhance customer experience RADNOR, Pa. , Sept. 30, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced today that the Company's NuSil brand has received the 2024 North American Daily Kaizen Management award from the Kaizen Institute.

What type of business is Avantor?

Avantor, Inc. is an American company specializing in the production of materials and equipment for the biopharmaceutical and healthcare industries. It has a history dating back to 1904 and was officially registered in its current form in 2017 in the state of Delaware. The portfolio of products and services includes: - Materials and consumables, including chemicals and reagents, laboratory products and consumables, specialized silicone materials, customized excipients, individual disposable assemblies, and more. - Equipment and instruments, such as filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low temperature freezers, biological safety cabinets, and materials for critical environments. - Services and specialized procurement, including laboratory and manufacturing services, procurement services, as well as services for the development of biopharmaceutical materials.

What sector is Avantor in?

Avantor is in the Healthcare sector

What industry is Avantor in?

Avantor is in the Medical Instruments & Supplies industry

What country is Avantor from?

Avantor is headquartered in United States

When did Avantor go public?

Avantor initial public offering (IPO) was on 17 May 2019

What is Avantor website?

https://www.avantorsciences.com

Is Avantor in the S&P 500?

No, Avantor is not included in the S&P 500 index

Is Avantor in the NASDAQ 100?

No, Avantor is not included in the NASDAQ 100 index

Is Avantor in the Dow Jones?

No, Avantor is not included in the Dow Jones index

When was Avantor the previous earnings report?

No data

When does Avantor earnings report?

The next expected earnings date for Avantor is 14 February 2025